Direct oral anticoagulants for stroke prevention in patients with device-detected atrial fibrillation: a study-level meta-analysis of the NOAH-AFNET 6 and ARTESiA trials

WF McIntyre, AP Benz, N Becher, JS Healey… - Circulation, 2024 - Am Heart Assoc
BACKGROUND: Device-detected atrial fibrillation (also known as subclinical atrial fibrillation
or atrial high-rate episodes) is a common finding in patients with an implanted cardiac …

[HTML][HTML] Фибрилляция и трепетание предсердий. Клинические рекомендации 2020

МГ Аракелян, ЛА Бокерия, ЕЮ Васильева… - Российский …, 2021 - cyberleninka.ru
Члены Рабочей группы подтвердили отсутствие финансовой поддержки/конфликта
интересов. В случае сообщения о наличии конфликта интересов, член (ы) Рабочей …

[HTML][HTML] Russian heart failure society, Russian society of cardiology. Russian scientific medical society of internal medicine guidelines for heart failure: chronic (CHF) …

VY Mareev, IV Fomin, FT Ageev, YL Begrambekova… - Kardiologiia, 2018 - lib.ossn.ru
РЕКОМЕНДАЦИИ, СЕРДЕЧНАЯ НЕДОСТАТОЧНОСТЬ, ХРОНИЧЕСКАЯ СЕРДЕЧНАЯ
НЕДОСТАТОЧНОСТЬ, ОСТРАЯ ДЕКОМПЕНСАЦИЯ СЕРДЕЧНОЙ …

Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial

JP Collet, E Van Belle, H Thiele, S Berti… - European Heart …, 2022 - academic.oup.com
Aims The respective roles of oral anticoagulation or antiplatelet therapy following
transcatheter aortic valve implantation (TAVI) remain debated. ATLANTIS is an international …

The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methods

H Kamel, WT Longstreth Jr… - … Journal of Stroke, 2019 - journals.sagepub.com
Rationale Recent data suggest that a thrombogenic atrial substrate can cause stroke in the
absence of atrial fibrillation. Such an atrial cardiopathy may explain some proportion of …

Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis

JA López-López, JAC Sterne, HHZ Thom, JPT Higgins… - bmj, 2017 - bmj.com
Objective To compare the efficacy, safety, and cost effectiveness of direct acting oral
anticoagulants (DOACs) for patients with atrial fibrillation. Design Systematic review …

[HTML][HTML] 2020 Clinical guidelines for Atrial fibrillation and atrial flutter

MG Arakelyan, LA Bockeria… - Russian Journal of …, 2021 - russjcardiol.elpub.ru
clinical guidelines, atrial fibrillation, ischemic stroke, anticoagulant therapy, vitamin K
antagonists, direct oral anticoagulants, triple antiplatelet therapy, rhythm control, electrical …

Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American …

JC Hemphill III, SM Greenberg, CS Anderson, K Becker… - Stroke, 2015 - Am Heart Assoc
Purpose—The aim of this guideline is to present current and comprehensive
recommendations for the diagnosis and treatment of spontaneous intracerebral …

Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for pharmacogenetics‐guided warfarin dosing: 2017 update

JA Johnson, KE Caudle, L Gong… - Clinical …, 2017 - Wiley Online Library
This document is an update to the 2011 Clinical Pharmacogenetics Implementation
Consortium (CPIC) guideline for CYP2C9 and VKORC1 genotypes and warfarin dosing …

National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the diagnosis and management of atrial …

D Brieger, J Amerena, JR Attia… - Medical Journal of …, 2018 - Wiley Online Library
Introduction: Atrial fibrillation (AF) is increasing in prevalence and is associated with
significant morbidity and mortality. The optimal diagnostic and treatment strategies for AF are …